Pharma Sales Reps May Get Overtime After Appeals Court Defers To Department Of Labor
This article was originally published in The Pink Sheet Daily
Executive Summary
Novartis plaintiffs seek at least $100 million in overtime; Second Circuit's ruling may impact similar suits against more than a dozen other companies.
You may also be interested in...
Novartis Settles Sales Rep Overtime Suit Rather Than Await Supreme Court Ruling
Novartis agrees to pay $99 million to resolve a class action on behalf of 7,700 current and former sales representatives. The company changed the duties of its reps and cut their work hours after the suit was filed.
Is A Pharma Sales Rep A Salesman? Supreme Court To Make Final Call
Court to decide whether sales reps qualify for overtime pay in case involving former GlaxoSmithKline reps; it is the third pharma case this term.
GSK Sales Reps Are Latest To Urge Supreme Court To Review Overtime Pay
The court is being asked for the second time to address whether pharmaceutical sales reps are exempt from receiving overtime pay under the Fair Labor Standards Act.